By David Bautz, PhD NASDAQ:ESLA Business Update On February 9, 2026, Estrella Immunopharma, Inc. (NASDAQ:ESLA) announced that ...

“For many cell-based therapies, progress comes from connecting the right pieces at the right moment,” Klein said. “When ...

B cells are a central component of the adaptive immune system, responsible for recognising pathogens and producing antibodies that neutralise infections. Their development, activation and ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During their preparation for this battle, B cells transiently revert to a more ...

As 2025 comes to a close, the editors at The Scientist asked researchers to reflect on the biggest breakthroughs in cell biology this year. They named advances in everything from embryo models for ...

Immunotherapy is the form of treatment that redirects the immune system toward a pathogen or disease. In many cases, immunotherapy is referred to treating cancer. As tumors progress, they secrete ...